Translation, cultural adaptation, and validation of the PHQ-9 and GAD-7 in Kinyarwanda for primary care in the United States

被引:0
|
作者
Muller, Frank [1 ,2 ,3 ]
Hansen, Alexis [1 ]
Kube, Megan [1 ,4 ]
Arnetz, Judith E. [1 ]
Alshaarawy, Omayma [5 ]
Achtyes, Eric D. [6 ]
Holman, Harland T. [1 ,2 ]
机构
[1] Michigan State Univ, Coll Human Med, Dept Family Med, Grand Rapids, MI 48823 USA
[2] Corewell Hlth Family Med Residency Clin, Grand Rapids, MI 49503 USA
[3] Univ Med Ctr Gottingen, Dept Gen Practice, Gottingen, Germany
[4] Trinity Hlth Livonia Hosp, Grad Med Educ Psychiat, Livonia, MI USA
[5] Michigan State Univ, Coll Human Med, Dept Family Med, E Lansing, MI USA
[6] Western Mchigan Univ, Homer Stryker MD Sch Med, Dept Psychiat, Kalamazoo, MI USA
来源
PLOS ONE | 2024年 / 19卷 / 10期
关键词
HEALTH; DEPRESSION; PREVALENCE; GUIDELINES; DIAGNOSIS; MORTALITY; VALIDITY; DISORDER; QUALITY; ANXIETY;
D O I
10.1371/journal.pone.0302953
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Depression and anxiety are significant health burdens that greatly impact the quality of life of refugees and migrants. In this study, we have translated and culturally adapted the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Screener (GAD-7) into Kinyarwanda and performed a validation study in a United States (US) primary care setting.Methods A committee of seven experts including psychiatric and family medicine providers, health researchers, and trained medical interpreters translated and culturally adapted the PHQ-9 and GAD-7, and incorporated feedback from cognitive interviews with bilingual participants. The translated instruments were then tested in a cross-sectional validation study. Analyses include internal consistency, discriminant validity, principal component analyses, and confirmatory factor analyses.Results Analyses of 119 responses indicated overall good internal consistency with Cronbach's alpha of 0.85 (PHQ-9) and 0.92 (GAD-7). Both scales showed acceptable factor loadings between 0.44 and 0.90 in the principal component analyses and showed strong correlations with health-related quality of life and depression/anxiety symptoms measured with visual analog scales. Significantly higher scores for PHQ-9 and GAD-7 were shown among participants with known psychiatric conditions.Discussion PHQ-9 and GAD-7 demonstrated commendable applicability for Kinyarwanda-speaking patients in primary healthcare settings in the US. Our instruments can already be used in primary care settings and thus help to mitigate health disparities. Future research should further validate our tool against gold-standard diagnostics in larger, geographically diverse samples.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Patient-reported outcome measures in community mental health teams: pragmatic evaluation of PHQ-9, GAD-7 and SWEMWBS
    Blenkiron, Paul
    Goldsmith, Lucy
    BJPSYCH BULLETIN, 2019, 43 (05): : 221 - 227
  • [32] Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome
    Snijkers, Johanna Theodora Wilhelmina
    Van Den Oever, Wendy
    Weerts, Zsa Zsa Regina Maria
    Vork, Lisa
    Mujagic, Zlatan
    Leue, Carsten
    Hesselink, Martine A. M.
    Kruimel, Joanna W.
    Muris, Jean W. M.
    Bogie, Roel M. M.
    Masclee, Ad A. M.
    Jonkers, Daisy M. A. E.
    Keszthelyi, Daniel
    NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (12)
  • [33] The Value of PHQ-9 and GAD-7 for Screening Emotional Disorders in IBS-D and the Specificity of the Gut Flora Associated with Emotional Comorbidity: Preliminary Findings
    Zhao, Jun
    Li, Xia
    Wang, Xin
    Wang, Xuefei
    Hao, Xin
    Li, Zhigang
    Zhu, Lin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2024, 20 : 2145 - 2158
  • [34] Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires
    Khairunnisa’ Md Yusof
    Sherina Mohd Sidik
    Rozi Mahmud
    Maha Abdullah
    Kelly A. Avery-Kiejda
    Rozita Rosli
    Breast Cancer, 2023, 30 : 810 - 819
  • [35] The theoretical and practical determination of clinical cut-offs for the British Sign Language versions of PHQ-9 and GAD-7
    Belk, Rachel A.
    Pilling, Mark
    Rogers, Katherine D.
    Lovell, Karina
    Young, Alys
    BMC PSYCHIATRY, 2016, 16
  • [36] Measurement invariance of the PHQ-9 and GAD-7 across males and females seeking treatment for common mental health disorders
    Saunders, Rob
    Moinian, Delilah
    Stott, Joshua
    Delamain, Henry
    Naqvi, Syed Ali
    Singh, Satwant
    Wheatley, Jon
    Pilling, Stephen
    Buckman, Joshua E. J.
    BMC PSYCHIATRY, 2023, 23 (01)
  • [37] Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold
    Butcher, Elizabeth
    Packham, Christopher
    Williams, Marie
    Miksza, Joanne
    Kaul, Adarsh
    Khunti, Kamlesh
    Morriss, Richard
    BMC PSYCHIATRY, 2021, 21 (01)
  • [38] Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS): performance in a clinical sample in relation to PHQ-9 and GAD-7
    Neha Shah
    Mizaya Cader
    Bill Andrews
    Rose McCabe
    Sarah L. Stewart-Brown
    Health and Quality of Life Outcomes, 19
  • [39] Quality control questions on Amazon's Mechanical Turk (MTurk): A randomized trial of impact on the USAUDIT, PHQ-9, and GAD-7
    Agley, Jon
    Xiao, Yunyu
    Nolan, Rachael
    Golzarri-Arroyo, Lilian
    BEHAVIOR RESEARCH METHODS, 2022, 54 (02) : 885 - 897
  • [40] Measurement invariance and differential item functioning of the PHQ-9 and GAD-7 between working age and older adults seeking treatment for common mental disorders
    Delamain, H.
    Buckman, J. E. J.
    Stott, J.
    John, A.
    Singh, S.
    Pilling, S.
    Saunders, R.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 347 : 15 - 22